Advertisement

HindustanTimes Fri,29 Aug 2014

RCom to sell subsidiary to Bahrain Tele, raise $1.1 bn: report

AFP  Mumbai, April 08, 2013
First Published: 20:04 IST(8/4/2013) | Last Updated: 20:22 IST(8/4/2013)

Indian mobile phone firm Reliance Communications (RCom) owned by Anil Ambani will sell a majority stake in a telecom subsidiary to a Bahrain Telecommunications-led group for $1.1 billion, a report said Monday.

Advertisement

The funds raised from the sale of the stake in Reliance Globalcom will help RCom reduce its hefty debt estimated at $6.7 billion, a report said, quoting a source the newspaper said was close to the deal.

"RCom will sell an 80% stake in its subsidiary, Reliance Globalcom, to a consortium led by Bahrain Telecommunications Company (Batelco)" for around Rs. 60 billion ($1.1 billion), the report said.

Reliance Globalcom provides voice, internet and other communication services and operates a US fibre-optic network and a management services business.

The Ambani group may also sell off its direct-to-home broadcast business to Sun Group based in south India for around $360 million, the newspaper added.

RCom shares rose as much as 6.74% to Rs. 67.25 on the back of the report.

The Batelco-led consortium would include private equity firms, the report added.

RCom would retain a 20% stake in Reliance Globalcom initially but has the option to sell that as well, the report said, adding the deal could be closed by May-end.

An RCom spokesman told AFP the company would not comment on "speculative news". There was no immediate comment available from Batelco.

Last week RCom signed a $220 million deal with Reliance Industries' group telecom firm, led by Anil's elder brother Mukesh, to share their fibre-optic communications networks.

The agreement between the billionaire Ambani brothers, who had battled for the spoils of their late father's business empire, was the first tangible sign of a corporate reconciliation.


Advertisement
more from Business

Sun-Ranbaxy deal: CCI raises concerns about molecules mkt

The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, said on Friday the major issue is whether the combination would result in high market concentration of certain molecules.

markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved